Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

AJVS. 2019; 63(2): 77-89


Camel Milk Mitigates Hemato-Immunotoxic Impacts of Fenpropathrin Oral Intoxication in Male Rat

Ehsan H. Abu zeid, Nabela I. El Sharkawy, Gihan G. Moustafa, Abeer M. Anwer, Ahmed G. Al Nady.




Abstract

Our study was done to investigate the hematological and immune related impacts of fenpropathrin (FNP) pyrethroid in male rats and to assess the mitigating effect of camel milk (CM). Sixty male rats were randomly separated into six equal groups (n=10). 1st control (C), 2nd corn oil (CO), 3rd camel milk (CM) groups were orally gavaged physiological saline, CO, and CM respectively at doses of 2ml/rat for 60 days. 4th (FNP treated); orally received FNP 7.06 mg/kg B.wt., 5th (CM+FNP pro/ co treated; received CM two weeks prior to and along with FNP), and 6th (FNP + CM co treated; received FNP followed by CM) day after day by the same previous doses, route, and duration. FNP intoxication significantly decreased RBC counts, HCT, MCHC, Hb content, phagocytosis %, phagocytic index, serum lysozyme activity, and IgM levels. FNP significantly increased leukogram, platelet count, TNFα and IL6. CM significantly attenuates the altered indices more significantly in the (CM+FNP pro/co treated) group than the (FNP+CM co treated) group. Spleen tissues of FNP treated rats revealed marked atrophy and hypocellularity of the lymphocytic follicles with apoptosis and necrosis of the lymphoied eliments. Furthermore; marked atrophy of thymic cortex with delination of cortex and medulla with multifocal lymphocytic deplation. It is concluded that CM significantly mitigates FNP induced alterations in hematological and immune related indices in male rats.

Key words: Fenpropathrin, Type II pyrethroids, Camel milk, Hematology, Immunotoxicity, Spleen, Thymus






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.